Key result
Levosimendan improved right ventricular systolic and diastolic functions and produced a greater decrease in systolic pulmonary artery pressure compared to dobutamine.
Why the study?
Does levosimendan improve right ventricular systolic and diastolic functions compared to dobutamine in patients with acute decompensated ischaemic heart failure?
Does levosimendan improve right ventricular systolic and diastolic functions compared to dobutamine in patients with acute decompensated ischaemic heart failure?
Levosimendan improves right ventricular systolic and diastolic functions and reduces pulmonary artery pressure more effectively than dobutamine in patients with acute decompensated ischaemic heart failure.
Answers are grounded in this paper and cite their sources.
May support levosimendan preference for RV function in acute HF; hypothesis-generating and requires RCTs before practice change.
OBJECTIVES: Levosimendan is a novel positive inotropic calcium sensitiser agent used in acute left heart failure. In this study, the effect of levosimendan on the right ventricular systolic and diastolic functions was evaluated by tissue Doppler comparing them with dobutamine in patients with ischaemic heart failure. METHODS: Patients having an acute decompensated heart failure with ischaemic cardiomyopathy and left ventricular ejection fraction <40% were included in the study. Before and 24-h after treatment, peak systolic (Sa), peak early (Ea), peak late (Aa) diastolic annular velocities and Ea/Aa ratio from tricuspid lateral annulus by tissue Doppler and systolic pulmonary artery pressure (SPAP) were measured. RESULTS: Sa, Ea and the Ea/Aa ratio were significantly increased in the levosimendan group whereas SPAP was significantly reduced. In the dobutamine group, no significant differences were observed in the Sa, Ea, Aa and Ea/Aa ratio in spite of a significant reduction in SPAP. Decrease in SPAP was greater in the levosimendan group (p=0.002). CONCLUSION: Levosimendan improves right ventricular systolic and diastolic functions.
No takes yet. Share an insight, caveat, or question.
Duygu et al. (2007) studied Acute decompensated heart failure with ischaemic cardiomyopathy. Levosimendan vs. Dobutamine was evaluated on Right ventricular systolic and diastolic functions (Sa, Ea, Aa, Ea/Aa ratio) and systolic pulmonary artery pressure (SPAP) (p=0.002). Levosimendan improved right ventricular systolic and diastolic functions and produced a greater decrease in systolic pulmonary artery pressure compared to dobutamine.
Synapse has enriched 10 related papers. Consider them for comparative context: